BPG is committed to discovery and dissemination of knowledge
Featured Articles
1/11/2023 8:06:59 AM | Browse: 297 | Download: 1174
 |
Received |
|
2022-09-09 09:43 |
 |
Peer-Review Started |
|
2022-09-09 09:45 |
 |
First Decision by Editorial Office Director |
|
2022-11-17 05:27 |
 |
Return for Revision |
|
2022-11-17 08:59 |
 |
Revised |
|
2022-11-25 18:41 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2022-12-14 04:07 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2022-12-14 20:56 |
 |
Articles in Press |
|
2022-12-14 20:56 |
 |
Edit the Manuscript by Language Editor |
|
2023-01-09 03:38 |
 |
Typeset the Manuscript |
|
2023-01-09 09:02 |
 |
Publish the Manuscript Online |
|
2023-01-11 07:15 |
| ISSN |
2308-3840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Liver dysfunction-related COVID-19: A narrative review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Taghreed S Saeed Al-Rawi and Raid M Al-Ani |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Raid M Al-Ani, MBChB, N/A, Academic Research, Full Professor, Senior Editor, Surgeon, Department of Surgery/Otolaryngology, University of Anbar College of Medicine, Al-Thaela, Ramadi City 31001, Anbar, Iraq. med.raed.alani2003@uoanbar.edu.iq |
| Key Words |
Liver dysfunction; Liver function test; SARS-CoV-2; Mortality; Critical illness; COVID-19 |
| Core Tip |
There is a diversity of clinical manifestations of the coronavirus 2019 disease (COVID-19), ranging from classical presentations like fever, cough, and dyspnea to non-classical presentations like liver involvement. Direct injury, drug-induced hypoxia, abnormal liver function tests, cytokine storm, and a history of chronic hepatic diseases are the proposed mechanisms of liver involvement during the COVID-19 course. Liver involvement can determine the severity of the disease. Old age and a history of chronic diseases like diabetes mellitus are recognized risk factors of this involvement. Autoimmune hepatitis is an example of liver involvement following COVID-19 vaccines. However, complete vaccination with 3rd and 4th booster doses is required in patients with chronic liver diseases. We aimed to summarize the various aspects of hepatic involvement during the COVID-19 course or following its vaccination. |
| Publish Date |
2023-01-11 07:15 |
| Citation |
Al-Rawi TSS, Al-Ani RM. Liver dysfunction-related COVID-19: A narrative review. World J Meta-Anal 2023; 11(1): 5-17
|
| URL |
https://www.wjgnet.com/2308-3840/full/v11/i1/5.htm |
| DOI |
https://dx.doi.org/10.13105/wjma.v11.i1.5 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.